Association Between Interstitial Lung Disease and Outcomes After Lung Cancer Resection

被引:8
作者
Axtell, Andrea L. [1 ]
David, Elizabeth A. [2 ]
Block, Mark I. [3 ]
Parsons, Niharika [4 ]
Habib, Robert [4 ]
Muniappan, Ashok [1 ,5 ]
机构
[1] Massachusetts Gen Hosp, Div Thorac Surg, Boston, MA USA
[2] Univ Colorado Hosp, Sect Thorac Surg, Aurora, CO USA
[3] Mem Healthcare Syst, Div Thorac Surg, Hollywood, FL USA
[4] Soc Thorac Surg Res Ctr, Chicago, IL USA
[5] Massachusetts Gen Hosp, Div Thorac Surg, 55 Fruit St, Austen 7, Boston, MA 02114 USA
关键词
IDIOPATHIC PULMONARY-FIBROSIS; SURVIVAL; IMPACT; TERM; EXACERBATION; PREDICTORS; SURGERY; RISK;
D O I
10.1016/j.athoracsur.2023.04.042
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Prior studies have noted that patients with interstitial lung disease (ILD) possess an increased incidence of lung cancer and risk of postoperative respiratory failure and death. We sought to understand the impact of ILD on national-scale outcomes of lung resection.METHODS A retrospective cohort analysis using The Society of Thoracic Surgeons General Thoracic Surgery Database was conducted of patients who underwent a pulmonary resection for non-small cell lung cancer between 2009 and 2019. Baseline characteristics and postoperative outcomes were compared between patients with and without ILD (defined as interstitial fibrosis based on clinical, radiographic, or pathologic evidence). Multivariable logistic regression models identified risk factors associated with postoperative mortality, acute respiratory distress syndrome, and composite morbidity and mortality.RESULTS ILD was documented in 1.5% (1873 of 128,723) of patients who underwent a pulmonary resection for non-small cell lung cancer. Patients with ILD were more likely to smoke (90% vs 85%, P < .001), have pulmonary hypertension (6% vs 1.7%, P < .001), impaired diffusing capacity of lung for carbon monoxide (diffusing capacity of lung for carbon monoxide 40%-75%: 64% vs 51%; diffusing capacity of lung for carbon monoxide <40%: 11% vs 4%, P < .001), and undergo more sublobar resections (34% vs 23%, P < .001) compared with patients without ILD. Patients with ILD had increased postoperative mortality (5.1% vs 1.2%, P < .001), acute respiratory distress syndrome (1.9% vs 0.5%, P < .001), and composite morbidity and mortality (13.2% vs 7.4%, P < .001). ILD remained a strong predictor of mortality (odds ratio, 3.94; 95% CI, 3.09-5.01; P < .001), even when adjusted for patient comorbidities, pulmonary function, extent of resection, and center volume effects.CONCLUSIONS ILD is a risk factor for operative mortality and morbidity after lung cancer resection, even in patients with normal pulmonary function.
引用
收藏
页码:533 / 541
页数:9
相关论文
共 20 条
  • [1] Interstitial Lung Abnormalities and Lung Cancer Risk in the National Lung Screening Trial
    Brown, Stacey-Ann Whittaker
    Padilla, Maria
    Mhango, Grace
    Powell, Charles
    Salvatore, Mary
    Henschke, Claudia
    Yankelevitz, David
    Sigel, Keith
    De-Torres, Juan P.
    Wisnivesky, Juan
    [J]. CHEST, 2019, 156 (06) : 1195 - 1203
  • [2] Treatment-Related Toxicity in Patients With Early-Stage Non-Small Cell Lung Cancer and Coexisting Interstitial Lung Disease: A Systematic Review
    Chen, Hanbo
    Senan, Suresh
    Nossent, Esther J.
    Boldt, R. Gabriel
    Warner, Andrew
    Palma, David A.
    Louie, Alexander V.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (03): : 622 - 631
  • [3] The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Kimura, Madoka
    Ono, Akira
    Shukuya, Takehito
    Nakamura, Yukiko
    Tsuya, Asuka
    Kaira, Kyoichi
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Endo, Masahiro
    Yamamoto, Nobuyuki
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (07) : 1242 - 1246
  • [4] Lung cancer in patients with idiopathic pulmonary fibrosis: Clinical characteristics and impact on survival
    Lee, Taehoon
    Park, Ji Young
    Lee, Hong Yeul
    Cho, Young-Jae
    Yoon, Ho Il
    Lee, Jae Ho
    Jheon, Sanghoon
    Lee, Choon-Taek
    Park, Jong Sun
    [J]. RESPIRATORY MEDICINE, 2014, 108 (10) : 1549 - 1555
  • [5] Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the New Millennium
    Nathan, Steven D.
    Shlobin, Oksana A.
    Weir, Nargues
    Ahmad, Shahzad
    Kaldjob, Julienne M.
    Battle, Edwinia
    Sheridan, Michael J.
    du Bois, Roland M.
    [J]. CHEST, 2011, 140 (01) : 221 - 229
  • [6] Predicting Severe Postoperative Complication in Patients With Lung Cancer and Interstitial Pneumonia
    Ohsawa, Manato
    Tsutani, Yasuhiro
    Fujiwara, Makoto
    Mimae, Takahiro
    Miyata, Yoshihiro
    Okada, Morihito
    [J]. ANNALS OF THORACIC SURGERY, 2020, 109 (04) : 1054 - 1060
  • [7] Okamoto Taku, 2004, Jpn J Thorac Cardiovasc Surg, V52, P323
  • [8] Cumulative incidence of and predictive factors for lung cancer in IPF
    Ozawa, Yuichi
    Suda, Takafumi
    Naito, Tateaki
    Enomoto, Noriyuki
    Hashimoto, Dai
    Fujisawa, Tomoyuki
    Nakamura, Yutaro
    Inui, Naoki
    Nakamura, Hirotoshi
    Chida, Kingo
    [J]. RESPIROLOGY, 2009, 14 (05) : 723 - 728
  • [9] Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial
    Palma, David A.
    Chen, Hanbo
    Bahig, Houda
    Gaede, Stewart
    Harrow, Stephen
    Laba, Joanna M.
    Qu, X. Melody
    Rodrigues, George B.
    Yaremko, Brian P.
    Yu, Edward
    Louie, Alexander, V
    Dhaliwal, Inderdeep
    Ryerson, Christopher J.
    [J]. BMC CANCER, 2019, 19 (01)
  • [10] A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation- part 4: systematic review of evidence involving SBRT and ablation
    Park, Henry S.
    Detterbeck, Frank C.
    Madoff, David C.
    Bade, Brett C.
    Kumbasar, Ulas
    Mase, Vincent J., Jr.
    Li, Andrew X.
    Blasberg, Justin D.
    Woodard, Gavitt A.
    Brandt, Whitney S.
    Decker, Roy H.
    [J]. JOURNAL OF THORACIC DISEASE, 2022, 14 (06) : 2412 - +